Achieving Transparency in the Startup Business Model

 
With the successes of businesses and companies like Facebook, Apple, and Uber, startups are more common than ever, as many niche markets with a startup business model have proven to be lucrative. But starting a new business idea and finding success within it doesn’t happen overnight. In fact, failure is more likely because getting into the startup arena is risky, according to Forbes, since 90 percent of startups fail.

The ones who do succeed, however, may have entered their market with a solid startup business model at the perfect time, or simply had beginner’s luck. Whichever one, there’s a lot of valuable advice to be given for that industry but transparency isn’t always transparent. Why is transparency important for the startup industry? How can companies become more transparent in their success stories?

On an episode of “What Just Happened?“, Christine Russo interviewed Rand Fishkin, Cofounder and CEO of SparkToro, about his journey as a startup founder, becoming an SEO expert and leader, the challenges he confronted, acquiring investments, and lessons learned as a business owner.

Prior to being the cofounder of SparkToro, Fishkin co-founded Moz, a premier SEO website and blog. As one of the first SEO resource tools available, the website was one-of-a-kind and used its own honest story with SEO to earn itself a very committed audience. It was also a perfect time because this was when search engines were improving SEO, per Search Engine Journal. This allowed Moz to reach more people and make their name.

“Over time that did build up a reputation and a brand for this company. Many, many people found the blog — there were not a lot of transparent stories and resources to learn SEO at the time, so a lot of people came to that site,” said Fishkin.

Russo and Fishkin also talked about …

● The highs and lows that startups experience

● Potential concerns that come with fundraising and seeking investments from venture
capitalists

● Fishkin’s events that encourage startup founders to be more transparentand discuss
adversity and struggles

“A lot of founders, when they get on stage, they tell you the rosy, glossed over the details, ‘Here’s how I’m the hero’ story, and I don’t get nearly as much value from that and I don’t love that nearly as much as the warts in all journeys,” said Fishkin.

Rand Fishkin is the Cofounder and CEO of SparkToro, a market research software company. He also founded Moz, which was one of the first SEO website tools available. Fishkin is an accomplished author; he has authored and co-authored books about SEO.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More